Followers | 17 |
Posts | 936 |
Boards Moderated | 0 |
Alias Born | 04/26/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 22, 2018 1:11:38 PM
Apremilast PASI 75 has weak positive correlations with the size of PGA/IGA > 3 proportion and mean BSA value. That makes intuitive sense because high values for both indicate wider spread of psoriasis. One can't really say that this means that prurisol scores in P2b will be better than those achieved in P2a, but one can say that there is no evidence of the opposite.
I made an another observation, which means I finally bothered to read UNVEIL trial report thru. Hello! Apremilast UNVEIL trial is a BSA outlier for a reason. That study went after low BSA, IGA = 3 subjects! And what that has to do with prurisol? In my predictions for prurisol 2b I used PASI 75 to IGA 0/1 ratio from UNVEIL. If I include tofacitinib and methotrexate trials we have 6 trials with the ratio over 0.9 (three over 1.1), 1 trial with the ratio at 0.7 and that trial is UNVEIL, a trial skewed on purpose. Looks like I was too cautious with my predictions.
That's all.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM